×

Edwards Lifesciences Income After Taxes 2010-2024 | EW

Edwards Lifesciences annual/quarterly income after taxes history and growth rate from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
  • Edwards Lifesciences income after taxes for the quarter ending September 30, 2024 was $0.362B, a 8.12% increase year-over-year.
  • Edwards Lifesciences income after taxes for the twelve months ending September 30, 2024 was $1.549B, a 16.66% increase year-over-year.
  • Edwards Lifesciences annual income after taxes for 2023 was $1.399B, a 8.05% decline from 2022.
  • Edwards Lifesciences annual income after taxes for 2022 was $1.522B, a 1.25% increase from 2021.
  • Edwards Lifesciences annual income after taxes for 2021 was $1.503B, a 82.55% increase from 2020.
Edwards Lifesciences Annual Income After Taxes
(Millions of US $)
2023 $1,399
2022 $1,522
2021 $1,503
2020 $823
2019 $1,047
2018 $722
2017 $584
2016 $570
2015 $495
2014 $811
2013 $389
2012 $292
2011 $237
2010 $218
2009 $229
Edwards Lifesciences Quarterly Income After Taxes
(Millions of US $)
2024-09-30 $362
2024-06-30 $366
2024-03-31 $351
2023-12-31 $470
2023-09-30 $335
2023-06-30 $254
2023-03-31 $341
2022-12-31 $398
2022-09-30 $344
2022-06-30 $406
2022-03-31 $374
2021-12-31 $335
2021-09-30 $340
2021-06-30 $490
2021-03-31 $338
2020-12-31 $310
2020-09-30 $325
2020-06-30 $-122
2020-03-31 $311
2019-12-31 $280
2019-09-30 $275
2019-06-30 $242
2019-03-31 $250
2018-12-31 $7
2018-09-30 $226
2018-06-30 $283
2018-03-31 $207
2017-12-31 $-3
2017-09-30 $170
2017-06-30 $186
2017-03-31 $230
2016-12-31 $159
2016-09-30 $141
2016-06-30 $127
2016-03-31 $143
2015-12-31 $141
2015-09-30 $118
2015-06-30 $113
2015-03-31 $123
2014-12-31 $109
2014-09-30 $95
2014-06-30 $547
2014-03-31 $60
2013-12-31 $75
2013-09-30 $77
2013-06-30 $93
2013-03-31 $144
2012-12-31 $89
2012-09-30 $69
2012-06-30 $68
2012-03-31 $65
2011-12-31 $63
2011-09-30 $52
2011-06-30 $58
2011-03-31 $64
2010-12-31 $65
2010-09-30 $48
2010-06-30 $58
2010-03-31 $48
2009-12-31 $48
2009-09-30 $74
2009-06-30 $48
2009-03-31 $61
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $42.814B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $199.883B 24.39
Intuitive Surgical (ISRG) United States $186.649B 97.58
Alcon (ALC) Switzerland $41.161B 27.54
IQVIA Holdings (IQV) United States $35.414B 19.51
IDEXX Laboratories (IDXX) United States $33.479B 39.43
DexCom (DXCM) United States $30.662B 46.18
Waters (WAT) United States $21.866B 32.33
STERIS (STE) Ireland $19.984B 23.01
SONOVA HOLDING (SONVY) Switzerland $19.343B 0.00
Hologic (HOLX) United States $16.281B 17.58
Fresenius Medical Care AG KGaA (FMS) Germany $12.998B 13.34
Sysmex ADR (SSMXY) Japan $11.450B 35.90
Globus Medical (GMED) United States $11.143B 28.22
Penumbra (PEN) United States $9.211B 90.22
Masimo (MASI) United States $9.025B 43.67
Teleflex (TFX) United States $8.316B 13.26
Glaukos (GKOS) United States $8.253B 0.00
Integer Holdings (ITGR) United States $4.433B 25.13
PROCEPT BioRobotics (PRCT) United States $4.340B 0.00
Veracyte (VCYT) United States $3.134B 94.05
Inari Medical (NARI) United States $3.033B 0.00
LivaNova (LIVN) United Kingdom $2.533B 14.62
Tandem Diabetes Care (TNDM) United States $2.354B 0.00
Nihon Kohden (NHNKY) Japan $2.318B 17.61
TransMedics (TMDX) United States $2.232B 70.75
Elekta AB (EKTAY) Sweden $2.095B 18.83
Integra LifeSciences Holdings (IART) United States $1.776B 9.28
RxSight (RXST) United States $1.393B 0.00
Alphatec Holdings (ATEC) United States $1.285B 0.00
Artivion (AORT) United States $1.177B 78.00
Pulse Biosciences (PLSE) United States $1.094B 0.00
OPKO Health (OPK) United States $0.990B 0.00
Paragon 28 (FNA) United States $0.897B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.728B 12.37
AxoGen (AXGN) United States $0.722B 0.00
Mesa Laboratories (MLAB) United States $0.717B 16.90
IRadimed (IRMD) United States $0.696B 37.63
ORTHOFIX MEDICAL INC (OFIX) United States $0.660B 0.00
SiBone (SIBN) United States $0.584B 0.00
OrthoPediatrics (KIDS) United States $0.554B 0.00
Semler Scientific (SMLR) United States $0.506B 26.63
Pacific Biosciences Of California (PACB) United States $0.493B 0.00
Treace Medical Concepts (TMCI) United States $0.490B 0.00
ClearPoint Neuro (CLPT) United States $0.429B 0.00
Tactile Systems Technology (TCMD) United States $0.411B 22.23
Delcath Systems (DCTH) United States $0.403B 0.00
AngioDynamics (ANGO) United States $0.365B 0.00
NeuroPace (NPCE) United States $0.346B 0.00
CVRx (CVRX) United States $0.330B 0.00
Inogen (INGN) United States $0.219B 0.00
Alpha Tau Medical (DRTS) Israel $0.217B 0.00
Anteris Technologies Global (AVR) Australia $0.199B 0.00
Accuray (ARAY) United States $0.196B 0.00
Sight Sciences (SGHT) United States $0.182B 0.00
KORU Medical Systems (KRMD) United States $0.178B 0.00
Nevro (NVRO) United States $0.139B 0.00
Atossa Genetics (ATOS) United States $0.121B 0.00
Sensus Healthcare (SRTS) United States $0.116B 12.46
LENSAR (LNSR) United States $0.101B 0.00
Spectral Diagnostics (EDTXF) Canada $0.099B 0.00
EDAP TMS S.A (EDAP) France $0.089B 0.00
Vicarious Surgical (RBOT) United States $0.082B 0.00
Monogram Orthopaedics (MGRM) United States $0.082B 0.00
908 Devices (MASS) United States $0.076B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
WORK Medical Technology Group (WOK) China $0.070B 0.00
InspireMD (NSPR) Israel $0.069B 0.00
Covalon Technologies (CVALF) Canada $0.061B 0.00
EnVVeno Medical (NVNO) United States $0.054B 0.00
Spectral AI (MDAI) United States $0.051B 0.00
Lucid Diagnostics (LUCD) United States $0.047B 0.00
Neuronetics (STIM) United States $0.045B 0.00
Rapid Micro Biosystems (RPID) United States $0.042B 0.00
Baird Medical Investment Holdings (BDMD) $0.034B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Accelerate Diagnostics (AXDX) United States $0.032B 0.00
Envoy Medical (COCH) United States $0.031B 0.00
DarioHealth (DRIO) United States $0.028B 0.00
NexGel (NXGL) United States $0.026B 0.00
Biosig Technologies (BSGM) United States $0.024B 0.00
Microbot Medical (MBOT) United States $0.019B 0.00
Adagio Medical Holdings (ADGM) United States $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.013B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.008B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.007B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00